Article

New Support for Bone Marrow Lesions as Predictors in Knee OA

Tell-tale bone lesions forecast knee pain in osteoarthritis over 8 years

Foong YC, Khan HI, Blizzard L, et al., The clinical significance, natural history and predictors of bone marrow lesion change over eight years. Arthritis Res Ther. (2014) Jul 14;16(4):R149. (Open access)

New or enlarged subchondral bone marrow lesions (BML) in knee osteoarthritis (OA) appear to be linked to an increase in pain over the years, according to a new study from Australia. This appears particularly true for men and for people with a family history of OA.

The study, which followed 198 men and women in their 50s (109 adult offspring of people who’d had a knee replacement and 89 controls) over a ten-year period also finds that body mass index and strenuous activity appear to be associated with an increase in the size of subchondral BMLs in knee OA.

Neither smoking nor the presence of radiographic damage were associated with BMLs in this study.

BMLs, also referred to as chronic bone marrow edema, arise in the subchondral bone as a result of damage from repetitive loading that does not heal properly. They are believed to play a key role in the pathogenesis of knee OA.

While the erosion of cartilage leading to joint space narrowing (JSN) is characteristic of OA, previous research has shown that the degree of JSN correlates poorly with the occurrence and severity of pain in knee OA. Loss of cartilage is believed to lead subchondral bone damage and bone marrow edema, which may be the source of pain in OA. People with painful knee OA are 2.5 times more likely to have BMLs.1

The researchers say this is the first study to look at the natural history of BMLs beyond three years.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.